Tenet Healthcare Corporation (FRA:THC1)
Germany · Delayed Price · Currency is EUR | Market Cap | 13.92B +9.3% |
| Revenue (ttm) | 18.61B +4.5% |
| Net Income | 1.48B +17.0% |
| EPS | 16.60 +26.8% |
| Shares Out | n/a |
| PE Ratio | 9.42 |
| Forward PE | 10.42 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | 159.00 |
| Previous Close | 161.00 |
| Day's Range | 159.00 - 159.00 |
| 52-Week Range | 126.00 - 210.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 24, 2026 |
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient... [Read more]
Financial Performance
In 2025, Tenet Healthcare's revenue was $21.31 billion, an increase of 3.07% compared to the previous year's $20.68 billion. Earnings were $1.41 billion, a decrease of -56.03%.
Financial numbers in USD Financial StatementsNews
Tenet to Report Its Second Quarter 2026 Results on July 24
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its second quarter 2026 results before the market opens on Friday, July 24, 2026, to be followed by a conference call at ...
Tenet Healthcare Transcript: Bank of America Global Healthcare Conference 2026
Q1 volumes improved sequentially, supporting a strong outlook and confidence in annual guidance. Growth strategies focus on high acuity services, ambulatory expansion, and operational efficiency through AI. Capital deployment prioritizes M&A and share repurchases, with a strong cash position maintained.
Tenet to Participate in the BofA Securities Health Care Conference
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities Health Care Conference on Wednesday, May 13, 2026.
Tenet Healthcare Earnings Call Transcript: Q1 2026
Q1 2026 saw revenues of $5.4B and adjusted EBITDA of $1.16B, both above expectations, driven by strong cost management and high-acuity growth. Guidance for 2026 is reaffirmed, with robust cash flow and continued capital deployment for M&A and share repurchases.
Tenet Healthcare Earnings release: Q1 2026
Tenet Healthcare released its Q1 2026 earnings on April 30, 2026, summarizing the period's financial results.
Tenet Healthcare Slides: Q1 2026
Tenet Healthcare has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Tenet Healthcare Quarterly report: Q1 2026
Tenet Healthcare has published its Q1 2026 quarterly earnings report on April 30, 2026.
Tenet Reports Strong First Quarter 2026 Results
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2026. "We delivered strong results in both the Ambulatory and Hosp...
Tenet Healthcare Proxy statement: Proxy filing
Tenet Healthcare filed a proxy statement on April 16, 2026, providing details for shareholder voting and corporate governance matters.
Tenet Healthcare Proxy statement: Proxy filing
Tenet Healthcare filed a proxy statement on April 16, 2026, providing details for shareholder voting and corporate governance matters.
Tenet to Report its First Quarter 2026 Results on April 30th
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its first quarter 2026 results before the market opens on Thursday, April 30, 2026, to be followed by a conference call a...
Tenet Healthcare Transcript: Barclays 28th Annual Global Healthcare Conference
Strong demand for high-acuity care and disciplined capital deployment support robust growth projections. AI and automation drive efficiency, while commercial rates remain favorable and ambulatory expansion continues. Capital priorities include service line investment, share buybacks, and debt reduction.
Tenet to Participate in the Barclays 28th Annual Global Healthcare Conference
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026, beginning at 9:30 a.m. Ea...
Tenet Healthcare Earnings Call Transcript: Q4 2025
2025 saw strong revenue and margin growth, with Adjusted EBITDA up 14% and robust free cash flow. 2026 guidance anticipates continued growth, though headwinds from expiring tax credits are expected. Capital deployment remains focused on M&A, share repurchases, and technology-driven efficiencies.
Tenet Healthcare Annual report: Q4 2025
Tenet Healthcare has published its Q4 2025 annual report on February 11, 2026.
Tenet Healthcare Earnings release: Q4 2025
Tenet Healthcare released its Q4 2025 earnings on February 11, 2026, summarizing the period's financial results.
Tenet Healthcare Slides: Q4 2025
Tenet Healthcare has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 11, 2026.
Tenet Reports Strong Fourth Quarter and FY 2025 Results; Provides 2026 Financial Outlook
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended December 31, 2025. "2025 extended Tenet's track record of strong revenue gro...
Tenet Healthcare Transcript: Status update
An accretive $2.65 billion asset sale of Conifer's contract with CommonSpirit strengthens cash flow, returns full strategic control, and enables accelerated investment in automation, AI, and offshoring. Capital allocation priorities remain focused on share repurchases and USPI growth.
Tenet Healthcare Press release: Status update
Tenet Healthcare issued a press release on February 2, 2026, disclosing material business information to investors.
Tenet Announces Accretive Transaction and Previews Strong 2025 Results
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the completion of a strategic transaction with CommonSpirit Health involving Tenet's Conifer Health Solutions subsidia...
Tenet to Report its Fourth Quarter 2025 Results on February 11th
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its fourth quarter 2025 results before the market opens on Wednesday, February 11, 2026, to be followed by a conference c...
Tenet Announces Upsizing and Pricing of Its $2.25 Billion Private Offerings of Senior Secured Notes and Senior Notes
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.5 billion in ag...
Tenet Announces Private Offerings of Senior Secured Notes and Senior Notes to Refinance $2.0 Billion in Outstanding Notes
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced private placement offerings of $1.5 billion in aggregate principal amount of new senior secured first lien notes due 2...
Tenet Healthcare Earnings Call Transcript: Q3 2025
Q3 2025 saw strong revenue and EBITDA growth, margin expansion, and robust free cash flow, prompting raised full-year guidance for revenue, EBITDA, and capital expenditures. USPI and hospital segments both delivered solid performance, with continued M&A activity and disciplined cost controls supporting future growth.